Antiangiogenic drugs as a novel anticancer therapeutic strategy - Which are the more promising agents? What are the clinical developments and indications?

被引：16
作者：
Gasparini, G [1 ]
机构：
[1] Azienda Osped Bianchi Melacrino Morelli, Div Oncol, I-89100 Reggio Calabria, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 1997年 / 26卷 / 03期
关键词：
D O I：
10.1016/S1040-8428(97)10001-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：147 / 162
页数：16
相关论文
共 122 条
[1]  
ABE J, 1994, CANCER RES, V54, P3407
[2]  
Alessandro R., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P184
[3]  
[Anonymous], 1994, RADIAT ONCOL INVEST
[4]   STIMULATION OF HUMAN B-LYMPHOCYTE PROLIFERATION BY AGM-1470, A POTENT INHIBITOR OF ANGIOGENESIS [J].
ANTOINE, N ;
BOURS, V ;
HEINEN, E ;
SIMAR, LJ ;
CASTRONOVO, V .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (02) :136-139
[5]  
ASANO M, 1995, CANCER RES, V55, P5296
[6]   ANGIOGENESIS INHIBITION - A REVIEW [J].
AUERBACH, W ;
AUERBACH, R .
PHARMACOLOGY & THERAPEUTICS, 1994, 63 (03) :265-311
[7]   Cancer undefeated [J].
Bailar, JC ;
Gornik, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (22) :1569-1574
[8]   TUMOR VASCULATURE - A POTENTIAL THERAPEUTIC TARGET [J].
BAILLIE, CT ;
WINSLET, MC ;
BRADLEY, NJ .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :257-267
[9]  
Belotti D, 1996, CLIN CANCER RES, V2, P1843
[10]   STIMULATION OF NK CELL, T-CELL, AND MONOCYTE FUNCTIONS BY THE NOVEL IMMUNOMODULATOR LINOMIDE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A PILOT-STUDY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA [J].
BENGTSSON, M ;
SIMONSSON, B ;
CARLSSON, K ;
NILSSON, B ;
SMEDMYR, B ;
TERMANDER, B ;
OBERG, G ;
TOTTERMAN, TH .
TRANSPLANTATION, 1992, 53 (04) :882-888
12345678910